Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial

Published 2020 View Full Article

Authors

Keywords

Amyotrophic lateral sclerosis, Randomised clinical trial, Low dose interleukin-2, Neuro-inflammation, Biomarkers, Regulatory T cells

Journal

EBioMedicine

Volume -, Issue -, Pages 102844

Publisher

Elsevier BV

Online

2020-07-07

DOI

10.1016/j.ebiom.2020.102844

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now